HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation.
Krakow EF, Brault M, Summers C, Cunningham TM, Biernacki MA, Black RG, Woodward KB, Vartanian N, Kanaan SB, Yeh AC, Dossa RG, Bar M, Cassaday RD, Dahlberg A, Till BG, Denker AE, Yeung CCS, Gooley TA, Maloney DG, Riddell SR, Greenberg PD, Chapuis AG, Newell EW, Furlan SN, Bleakley M.
Krakow EF, et al. Among authors: greenberg pd.
Blood. 2024 Sep 5;144(10):1069-1082. doi: 10.1182/blood.2024024105.
Blood. 2024.
PMID: 38683966
Clinical Trial.